Financhill
Sell
25

LFMD Quote, Financials, Valuation and Earnings

Last price:
$4.00
Seasonality move :
13.67%
Day range:
$3.59 - $4.04
52-week range:
$3.18 - $15.84
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.71x
P/B ratio:
146.52x
Volume:
3M
Avg. volume:
1.6M
1-year change:
-18.53%
Market cap:
$192.5M
Revenue:
$212.5M
EPS (TTM):
-$0.17

Earnings Data

Next earnings date for LFMD
Mar 10
2026
Most recent earnings per share
-$0.10
Missed by $0.14
(Nov 17/2025)
Consensus Estimate
$0.05
(Nov 17/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

LFMD Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/10/2026 Q4 $48.6M -- -- $0.01 --
11/17/2025 Q3 $62.1M $60.2M -$0.10 $0.05 -$0.14
08/05/2025 Q2 $66.3M $62.2M -$0.06 $0.18 -$0.24
05/06/2025 Q1 $62.5M $65.7M $0.01 $0.14 -$0.13
03/10/2025 Q4 $57.4M $64.3M -$0.02 $0.14 -$0.16
11/07/2024 Q3 $53.8M $53.4M -$0.14 $0.07 -$0.21
08/07/2024 Q2 $48.2M $50.7M -$0.19 $0.04 -$0.23
05/08/2024 Q1 $42.6M $44.1M -$0.19 -$0.01 -$0.18
03/11/2024 Q4 $40.5M $44.9M -$0.12 $0.03 -$0.15
11/08/2023 Q3 $38.2M $38.6M -$0.20 $0.03 -$0.23
08/09/2023 Q2 -- $35.9M -$0.23 -- --
05/12/2023 Q1 -- $33.1M -$0.15 -- --
03/22/2023 Q4 -- $28.1M -$0.40 -- --
11/10/2022 Q3 -- $31.4M -$0.26 -- --
08/11/2022 Q2 -- $30.5M -$0.45 -- --
05/13/2022 Q1 -- $29M -$0.46 -- --
03/07/2022 Q4 -- $27.4M -$0.62 -- --
11/10/2021 Q3 -- $24.9M -$0.54 -- --
08/12/2021 Q2 -- $22.3M -$0.64 -- --
05/13/2021 Q1 -- $18.2M -$0.47 -- --
03/29/2021 Q4 -- $12.9M -$2.56 -- --
11/16/2020 Q3 -- $11M -$1.65 -- --
06/30/2020 Q2 -- $9.1M -$0.27 -- --
03/31/2020 Q1 -- $4.3M -$0.22 -- --
12/31/2019 Q4 -- $3.9M -$0.07 -- --
09/30/2019 Q3 -- $3.1M -$0.09 -- --
06/30/2019 Q2 -- $2.7M -$0.09 -- --
03/31/2019 Q1 -- $2.7M -$0.07 -- --
12/31/2018 Q4 -- $2.2M -$0.09 -- --
09/30/2018 Q3 -- $2M -$0.12 -- --
06/30/2018 Q2 -- $2M -$0.05 -- --
03/31/2018 Q1 -- $1.6M $0.05 -- --
12/31/2017 Q4 -- $98.2K -$0.03 -- --
09/30/2017 Q3 -- $2.1M -$0.08 -- --
06/30/2017 Q2 -- $660.1K $0.10 -- --
03/31/2017 Q1 -- $167.9K -$0.15 -- --
12/31/2016 Q4 -- $985.9K -$0.09 -- --
09/30/2016 Q3 -- $1.4M -$0.05 -- --
06/30/2016 Q2 -- $1.2M -$0.05 -- --
03/31/2016 Q1 -- $1.6M -$0.01 -- --
12/31/2015 Q4 -- $373.3K -$0.01 -- --

LifeMD, Inc. Earnings Questions

  • How Much did LifeMD, Inc. Generate in Revenue Last Quarter?

    LifeMD, Inc. reported $60.2M worth of top line sales in its most recent quarter.

  • Did LifeMD, Inc. Beat Earnings Last Quarter?

    LifeMD, Inc. announced earnings per share of -$0.10 which represents a miss of analyst forecast a $0.05 per share.

  • Is LifeMD, Inc. Profitable?

    LifeMD, Inc. reported $50M that represents $1.08 per share over the last quarter.

  • What is the Analyst Consensus for LifeMD, Inc. EPS Next Year?

    LifeMD, Inc.'s earnings are forecast to grow from -$0.53 per share to $0.20 per share next year representing an increase of --.

  • When is LifeMD, Inc.'s Earnings Date?

    LifeMD, Inc.'s next earnings date is March 10, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock